Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-05-16 @ 3:46 PM
Study NCT ID:
NCT06008106
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2023-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Sponsor:
Shanghai Kechow Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HL-085-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None